Long-term Follow-up of a Randomized Phase II Study of Cisplatin/5-FU Concurrent Chemoradiotherapy for Esophageal Cancer (KROSG0101/JROSG021)

Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey

(2011) Yasumasa Nishimura et al.   International Journal of Clinical Oncology

Therapy-related leukemia following chemoradiotherapy for esophageal cancer

(2010) Naoya Mimura et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Phase II Study of Chemoradiotherapy With 5-Fluorouracil and Cisplatin for Stage II–III Esophageal Squamous Cell Carcinoma: JCOG Trial (JCOG 9906)

(2010) Ken Kato et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Current Management of Cervical Esophageal Cancer

(2010) Daniel King Hung Tong et al.   WORLD JOURNAL OF SURGERY

A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer: Short-term infusion versus protracted infusion chemotherapy (KROSG0101/JROSG021)

(2009) Yasumasa Nishimura et al.   RADIOTHERAPY AND ONCOLOGY

Concurrent Chemoradiotherapy for Esophageal Cancer With Malignant Fistula

(2008) Ryuta Koike et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Risk Factors for Pericardial Effusion in Inoperable Esophageal Cancer Patients Treated With Definitive Chemoradiation Therapy

(2008) Xiong Wei et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Long-Term Outcomes and Toxicity of Concurrent Paclitaxel and Radiotherapy for Locally Advanced Head-and-Neck Cancer

(2008) Deborah Citrin et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS